Millennium Pharmacy Systems, Inc.

Develops medication management systems for the long-term care industry

Turnkey pharmacy service solution for long term care facilities

Millennium Pharmacy Systems (MPS) is a leading pharmacy service provider that integrates an institutional pharmacy with a proprietary medication management system to offer a turnkey system (fully-integrated hardware, software, and management reporting) controlling distribution, administration, and documentation of prescriptions within a long term care facility (LTC). MPS is the first and only company to bring this end-to-end functionality to the LTC facility, allowing its customers to achieve better care, lower cost, and increased compliance. Headquartered in Cranberry Township, PA, Millennium has a strong presence on the east coast and is led by an experienced team of industry veterans.

Essex Woodlands acquired a minority stake in MPS in 2007 and continues to be a strong partner for the company as it actively leverages its technology to drive significant value for its customers—decreasing medication errors, reducing waste and returns, minimizing inventory, and improving cash flow.

  • Oak Brook, IL

  • Contact:
  • Formerly Known As: Millennium Pharmacy System
  • Acquisition
  • Acquired by: PharMerica
  • Exit date: September 26, 2014
  • Logo

Related News

“The breadth of business insights and healthcare intelligence that Essex Woodlands has shared with Millennium has demonstrated their commitment to the growth and evolution of our Company in a challenging marketplace. Their availability and collaborative support has positively impacted our approach to our business. ”

Philip J. Keough, IV

President and Chief Executive Officer

Testimonials and endorsements reflect portfolio company management’s opinions and beliefs regarding the company and the investment. Such opinions and beliefs are subjective, do not represent a complete assessment of the company, the market or EW’s overall investment performance and cannot be independently verified. Such statements are being offered as references for purposes of demonstrating the benefits of working with the EW team and not for the purpose of soliciting investors. Portfolio company executives receive/received a salary and economics from the portfolio company. No executives were paid for their testimonial or endorsement. There is a conflict of interest in these unpaid testimonials and endorsements in that all speakers stand to benefit from EW’s success and they work/worked for an EW portfolio company.